Alnylam Pharmaceuticals has announced a $250 million investment to expand its US manufacturing...
NEWS
Lilly Phase 3 trial shows oral GLP-1 maintains weight loss after...
Eli Lilly has reported Phase 3 results showing that its investigational oral GLP-1 therapy...
Sanofi to acquire Dynavax, expanding adult vaccine portfolio
Sanofi has agreed to acquire Dynavax Technologies Corporation, adding an approved adult hepatitis B...
University of Stirling Uses Immersive Pandemic Simulation to...
The University of Stirling has introduced an immersive pandemic simulation designed to prepare...

